To evaluate the dynamics of HIV in different tissue compartments of maximally suppressive antiretroviral (ART) medications with IL-2 influences, viral pathogenesis and immune responses to HIV infection. Throughout study [clinicaltrials_resource:bc56ff997016dcaa8471d38f50d48e0f]
Patients beginning IL-2 treatment regimens after 4 weeks of study
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
To evaluate the dynamics of HIV in different tissue compartments of maximally suppressive antiretroviral (ART) medications with IL-2 influences, viral pathogenesis and immune responses to HIV infection. Throughout study [clinicaltrials_resource:bc56ff997016dcaa8471d38f50d48e0f]
Patients beginning IL-2 treatment regimens after 4 weeks of study
Bio2RDF identifier
bc56ff997016dcaa8471d38f50d48e0f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bc56ff997016dcaa8471d38f50d48e0f
measure [clinicaltrials_vocabulary:measure]
To evaluate the dynamics of HI ...... ne responses to HIV infection.
time frame [clinicaltrials_vocabulary:time-frame]
Throughout study
description
Patients beginning IL-2 treatment regimens after 4 weeks of study
identifier
clinicaltrials_resource:bc56ff997016dcaa8471d38f50d48e0f
title
To evaluate the dynamics of HI ...... IV infection. Throughout study
@en
type
label
To evaluate the dynamics of HI ...... 6ff997016dcaa8471d38f50d48e0f]
@en